0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Editorial | 
Joshua M. Sharfstein, MD; Aaron S. Kesselheim, MD, JD, MPH
JAMA. 2015;314(3):233-234. doi:10.1001/jama.2015.7151.

Editorial | 
Phil B. Fontanarosa, MD, MBA; Howard Bauchner, MD; Robert M. Golub, MD
JAMA. 2015;314(3):235-236. doi:10.1001/jama.2015.8232.

News From the Centers for Disease Control and Prevention | 
Anita Slomski, MA
JAMA. 2015;314(2):116. doi:10.1001/jama.2015.7236.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(1):17. doi:10.1001/jama.2015.7109.

News From the Food and Drug Administration | 
Rita Rubin, MA
JAMA. 2015;313(17):1704. doi:10.1001/jama.2015.4114.

Editorial | 
Charles L. Campbell, MD; David J. Moliterno, MD
JAMA. 2015;313(8):801-802. doi:10.1001/jama.2015.0567.

Original Investigation | 
Anne-Marie Schjerning Olsen, MD, PhD; Gunnar H. Gislason, MD, PhD; Patricia McGettigan, MD; et al.
JAMA. 2015;313(8):805-814. doi:10.1001/jama.2015.0809.
Includes: Supplemental Content

Original Investigation | 
Barthelemy Diouf, PharmD, PhD; Kristine R. Crews, PharmD; Glen Lew, MD; et al.
JAMA. 2015;313(8):815-823. doi:10.1001/jama.2015.0894.
Includes: Supplemental Content

Viewpoint | 
Marc B. Garnick, MD
JAMA. 2015;313(6):563-564. doi:10.1001/jama.2014.17334.

Viewpoint | 
Muthiah Vaduganathan, MD, MPH; Vinay Prasad, MD, MPH
JAMA. 2014;312(24):2619-2620. doi:10.1001/jama.2014.15221.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Original Investigation  | 
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Martina Sanlorenzo, MD; Igor Vujic, MD; Adil Daud, MD; et al.
JAMA Internal Medicine
Research Letter  | 
Disclosure of Boxed Warnings to Research Participants
Tanya Bhattacharya, BS; Debra G. Tice, MS; Pranathi Lingam, MD; et al.
JAMA Internal Medicine
Research Letter  | 
Drug Manufacturers’ Delayed Disclosure of Serious and Unexpected Adverse Events to the US Food and Drug Administration
Paul Ma, PhD; Iván Marinovic, PhD; Pinar Karaca-Mandic, PhD
JAMA Internal Medicine
Perspective  | 
“Mom, You Have to Trust Me”
Mary K. Brennan-Taylor, BA